The role of boron MRI in boron neutron capture therapy

Journal of Neuro-Oncology

Volumn 33, Issue 1-2, 1997, Pages 153-161

  Kabalka, George W ^a   Tang, Chao ^a   Bendel, Peter ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

BNCT; Boron; Imaging center; MRI; MRS

Indexed keywords

BORON; BORON DERIVATIVE;

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG DISTRIBUTION; GLIOBLASTOMA; HUMAN; IMAGING; MAGNETISM; NEUTRON CAPTURE THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SPECTROSCOPY; TECHNIQUE; TREATMENT PLANNING;

EID: 0030934131     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1005793903512     Document Type: Article

References (42)

1. Barth RF, Soloway AH, Fairchild RG, Brugger RM: Boron neutron capture therapy for cancer: realities and prospects. Cancer 70: 2995-3007, 1992
2. Barth RF, Soloway AH, Fairchild RG: Boron neutron capture therapy of cancer. Cancer Res 50: 1061-1076, 1990
3. Soloway AH, Barth RF, Carpenter DE: Advances in Neutron Capture Therapy. Plenum Press, New York, 1993
4. Coderre J, Rubin P, Freedman A, Hansen J, Wooding TS, Joel D, Gash D: Selective ablation of rat brain tumors by boron neutron capture therapy. Int J Radiation One Biol Phys 28: 1067-1077, 1994
5. Farr LE, Sweet WH, Robertson JS, Foster CG, Locksley HB, Sutherland DL, Mendelsohn ML, Stickley EE: Neutron capture therapy with boron in the treatment of glioblastoma multiforme. Am J Roentgenol 71: 279-293, 1954
6. Sweet WH, Javid M: The possible use of neutron-capturing isotopes such as boron-10 in the treatment of neoplasms. I Intracranial tumor. J Neurosurg 9: 299-209, 1952
7. Hatanaka H, Nakagawa Y: Clinical results of long surviving brain tumor patients who underwent boron neutron capture therapy. Int J Radiat Oncol Biol Phys 28: 1061-1066, 1994
8. Coderre JA, Bergland R, Chadha M, Chanana AD, Elowitz E, Joel DD, Lin HB, Slatkin DN, Wielopolski L: Boron neutron capture of glioblastoma multiforme using p-boronophenylalanine-fructose complex and epithermal neutrons. (Abstract). In: Proceedings of the sixth international symposium on neutron capture therapy. p. 36, 1994
9. Coderre JA, Joel DD, Micca PL, Nawrocky MM, Slatkin DN: Control of intracerebral gliosarcoma in rats by boron neutron capture therapy with p-boronophenylalanine. Rad Res 129: 290-296, 1992
10. Coderre JA, Button TM, Micca PL, Fisher CD, Nawrocky MM, Liu HB: Neutron capture therapy on the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. Int J Rad Oncol Biol Phys 30: 643-652, 1994
11. Kabalka GW, Davis M, Bendel P: Boron-11 MRI and MRS of intact animals infused with a boron-neutron-capture agent. J Magn Reson Med 8: 231-237, 1988
12. Kabalka GW, Bendel P, Davis M, Slatkin DN, Micca PL: Boron-11 magnetic resonance imaging and spectroscopy: tools for investigating pharmokinetics for boron neutron capture therapy. In: Fairchild RG, Bond JP (eds) Clinical Aspects of Neutron Capture Therapy, Plenum Press, New York, pp 243-249, 1989
13. Bendel P, Kabalka GW, Davis M: Boron-11 MRI and MRS of intact animals infused with boron compounds used in neutron capture therapy. (Abstract). In: Proceedings of society of magnetic resonance in medicine, National meeting, p 601, 1988
14. Kabalka GW, Bendel P, Davis MA: Boron-11 MRI and MRS of intact animals infused with an agent used in boron-neutron-capture-therapy. (Abstract). In: Proceedings of The American Chemical Society Regional Meeting, ORG 553, 1988
15. Harris RK, Mann BE: NMR and the Periodic Table. Academic Press, London, pp 91-93, 1978
16. Monoi H: Nuclear magnetic resonance of ions with quadrupole nuclei in aqueous heterogeneous systems: Basic theory and applications. Rev Magn Reson Med 1: 73-122, 1986
17. Kabalka GW, Cheng GQ, Bendel P: Boron-11 MRI and MRS. In: Blümich B, Kuhn W (eds) Magnetic Resonance Microscopy, Methods and Application in Materials Science, Agriculture and Biomedicine. VCH, Weinheim. pp 533-545, 1992
18. Richards TL, Bradshaw KM: 10B versus 11B signal-to-noise comparison at 2 testla. (Abstract). In: Proceedings of The Society of Magnetic Resonance in Medicine 8th Annual meeting, p 665, 1991
19. Lai CM, Lauterbur PC: True three dimensional image reconstruction by nuclear magnetic resonance zeugmatography. Phys Med Biol 26: 851-856, 1981
20. 4 in the rat. (Abstract). In: Proceedings of The Society of Magnetic Resonance in Medicine Annual Meeting, 1991.
21. Kabalka GW, Bendel P, Cheng GQ: Boron MRI and MRS. (Abstract). In: Proceedings of The International Conference on NMR Microscopy, 1991.
22. 11B of intact tissues using magnetic resonance gradient echoes. Strahlenther Onkol 165: 179-181, 1989
23. 11SH. (Abstract). In: Proceedings of The Society of Magnetic Resonance in Medicine 9th Annual Meeting, p 1166, 1990
24. Bendel P, Davis M, Berman E, Kabalka GW: A method for imaging nuclei with short T2 relaxation: Application to boron-11 MR imaging of a BNCT agent in an intact rat. J Mag Reson 88: 369-375, 1990
25. 4 in the rat. J Magn Reson Imag 9: 969-973, 1991
26. Kabalka GW, Cheng QC, Bendel P, Slatkin DN, Micca PL: Boron MRI method for imaging BNCT agents. In: Progress in Neutron Capture Therapy for Cancer, Plenum Press, New York, p 321-323, 1992
27. Glover GH, Pauly JM, Bradshaw KM: Boron-11 imaging with a three-dimensional reconstruction method. J Magn Reson Imaging 2: 47-53, 1992
28. 11B MRI. Mag Reson Med 34: 48-56, 1995
29. Bauer WF, Bradshaw KM, Richards TL: Interaction between boron containing compounds and serum albumin observed by nuclear magnetic resonance. In: Allen BJ, Moore DE, Harrington BV (eds) Progress in Neutron Capture Therapy for Cancer. Plenum Press, New York, pp 339-343, 1992
30. 11B Nuclear magnetic resonance studies of the interaction of borocaptate sodium with serum albumin. Biochem Pharm 49: 625-632, 1995
31. Kabalka GW, Cheng GQ, Anderson CL, Bendel P, Micca P, Slatkin DN: Pharmacokinetics of BNCT agents via boron-11 MRS and MRI. (Abstract). In: Proceedings of The International Symposium on Neutron Capture Therapy, 1992
32. Kabalka GW, Cheng QC, Anderson CL, Bendel P, Micca P, Slatkin DN: In vivo pharmacokinetics of a boron neutron capture agent in a tumor-bearing rat via boron-11 MRS and MRI. In: Barth RF, Soloway AH (eds) Advances in Neutron Capture Therapy. Plenum Press NY, p 491-494, 1993
33. Bradshaw KM, Richards TL, Kraft SL: In vivo pharmacokinetic evaluation of boron compounds using magnetic resonance spectroscopy and imaging. In: Allen BJ, Moore DE, Harrington BV (eds) Progress in Neutron Capture Therapy for Cancer. Plenum Press, New York, pp 325-329, 1993
34. Kabalka GW: In vivo biodistribution and pharmacokinetics of BNCT agents using PET and MRI. Quart J Nucl Med 39: 301, 1995
35. 11B 3D projection reconstruction to determine in vitro boron concentration when bound to albumin. (Abstract). In: Proceedings of the society of magnetic resonance in medicine 12th Annual Meeting p889, 1993
36. 11SH in a patient with glioblastoma. Cancer Res 54: 6318-6320, 1994
37. Bendel P, Zilberstein J, Salomon Y, Kabalka GW: Non invasive in vivo detection of boron-10 by magnetic resonance: Application to mouse melanoma and prospects for humans. In: Mishima Y (ed) Cancer Neutron Capture Therapy. Plenum Inc, in press
38. 10B double resonance. Mag Reson Med 32: 170-174, 1994
39. Abragam A: The Principles of Nuclear Magnetism, Clarendon Press, Oxford, 82-83, 1961
40. Kabalka GW, Anderson CL, Bendel P, Cheng GQ: The boron-11 MRS and MRI studies of the boron neutron captures agents BSSB and VCDP at 9.4 tesla. A new application of NMR microscopy. (Abstract). In: Proceedings of The American Chemical Society Annual Meeting, Nucl 156, 1993
41. Roemer PB, Edelstein WA, Hayes CE, Souza SP, Mueller OM: The NMR phased array, Magn Reson Med 16: 192-225, 1990
42. Hu X, Levin DN, Lauterbur PC, Spraggins T: SLIM: Spectral localization by imaging. Magn Reson Med 8: 314-322, 1988